Mitsuharu Osawa
Overview
Explore the profile of Mitsuharu Osawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishibashi T, Takao Y, Ishibashi T, Sakai Y, Fujimoto Y, Osawa M, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi
. 2024 Nov;
81(1).
PMID: 39603652
Purpose: The objective of this study is to elucidate the current status of procedural radiation doses for endovascular treatment (EVT) of lower extremity artery disease (LEAD) in Japan and to...
2.
Osawa M, Fujita N, Koyama S, Kaneda N, Miyachi S
J Neuroendovasc Ther
. 2024 Aug;
18(8):213-218.
PMID: 39166097
Objective: The angiography systems A (A) and B (B), both incorporated at our hospital, are equipped with metal artifact reduction (MAR) applications. In clinical practice, it is crucial to understand...
3.
Osawa M, Nagata A, Saijo T, Yamada T, Sugimoto N, Tokudome A, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi
. 2023 Nov;
80(1):66-76.
PMID: 37967943
Purpose: National diagnostic reference levels in Japan 2020 (DRLs 2020) have been published. In the field of angiography, in addition to the fluoroscopic dose rate, incident air kerma at the...
4.
Yamashita K, Ueno H, Haba T, Ito Y, Matsunaga Y, Hirosawa A, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi
. 2023 Feb;
79(3):241-251.
PMID: 36724920
The present study investigated how effective an L-shaped shield was, depending on its position, in reducing a doctor's exposure to radiation during catheterization to access the transradial approach (TRA). The...
5.
Osawa M, Tawada Y, Kaneda N, Fujita N, Koyama S
Radiat Prot Dosimetry
. 2022 Nov;
198(20):1585-1597.
PMID: 36321327
The International Commission on Radiological Protection (ICRP) 118th recommendation significantly reduced the threshold dose for cataract development from 8 to 0.5 Gy. Equivalent dose limits for the crystalline lenses of...
6.
Soen S, Arai Y, Matsuda S, Emori K, Ikezaki T, Osawa M
Osteoporos Sarcopenia
. 2021 Jan;
6(4):191-198.
PMID: 33426308
Objectives: This postmarketing study aims to evaluate the safety and effectiveness of oral administration of risedronate at 75 mg once monthly for 36 months in patients with osteoporosis in Japan....
7.
Soen S, Umemura T, Ando T, Kamisaki T, Nishikawa M, Muraoka R, et al.
J Bone Miner Metab
. 2016 Aug;
35(4):419-427.
PMID: 27565972
Currently, the only available evidence for the efficacy of once-weekly 17.5 mg risedronate in preventing vertebral fractures was obtained in a 48-week study in Japan. We performed a 156-week prospective,...
8.
Nakamura T, Osawa M, Itoh M, Yamaguchi H, Iinuma N, Hayakawa Y, et al.
J Bone Miner Metab
. 2012 Aug;
30(6):715-21.
PMID: 22868656
A prospective observational study to test the effects of risedronate 17.5 mg/week treatment on quality of life (QOL) of 1,363 Japanese female patients with osteoporosis showed QOL improvement after 12 ...